{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:10:42Z","timestamp":1790363442690,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,1,9]],"date-time":"2015-01-09T00:00:00Z","timestamp":1420761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Our objective was to find out if there are antibodies binding to homocitrulline-containing type I and II collagen carboxyterminal telopeptides in sera of patients with rheumatoid arthritis (RA), and if these antibodies cross-react with citrulline and homocitrulline in the same peptide sequence.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A total of 72 RA and 72 control sera were analyzed for binding using enzyme-linked immunosorbent assay to citrulline- or homocitrulline-containing type I and II collagen carboxyterminal telopeptides, as well as to cyclic citrullinated peptide (CCP) and to mutated citrullinated vimentin (MCV). Specificities of the antibodies were tested using inhibition-ELISA.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Of the RA sera, 39 (54%) and 41 (57%) were positive for binding to CCP and MCV, respectively. Further, 34 (47%) and 30 (42%) of the patients had specific antibodies binding to and being inhibited by citrulline-containing type I collagen telopeptides and by citrulline-containing type II collagen carboxyterminal telopeptides, respectively. The corresponding figures regarding homocitrulline-containing type I and homocitrulline-containing type II collagen telopeptides were 16 (22%) and 14 (19%). Most of the patients, who were seropositive for citrullinated peptides, showed binding in multiple assays. A total of 10 (14%) RA patients were positive for all the tested peptide pairs, while 28 (39%) of them had antibodies that contained overlapping specifities between citrulline and homocitrulline in the same peptide sequence.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Antibodies to both citrulline and homocitrulline containing type I and II collagen telopeptides can be found in sera of RA patients. These antibodies are not constant from one RA patient to another, but contain separate or overlapping specificities within the same peptide sequence varying between individuals. Our results suggest some relationship between citrulline and homocitrulline-recognizing antibodies, since homocitrulline antibodies exist mainly in individuals seropositive to anti-CCP and anti-MCV.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0515-z","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T20:18:32Z","timestamp":1420748312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Separate and overlapping specificities in rheumatoid arthritis antibodies binding to citrulline- and homocitrulline-containing peptides related to type I and II collagen telopeptides"],"prefix":"10.1186","volume":"17","author":[{"given":"Sanna","family":"Turunen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Hannonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Kaisa","family":"Koivula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Risteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Risteli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,9]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u20136.","journal-title":"Arthritis Rheum."},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/ard.2006.062919","volume":"66","author":"MK Koivula","year":"2007","unstructured":"Koivula MK, Heliovaara M, Ramberg J, Knekt P, Rissanen H, Palosuo T, et al. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis. Ann Rheum Dis. 2007;66:1450\u20135.","journal-title":"Ann Rheum Dis."},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/art.30537","volume":"63","author":"LA van de Stadt","year":"2011","unstructured":"van de Stadt LA, de Koning MH, van de Stadt RJ, Wolbink G, Dijkmans BA, Hamann D, et al. Development of the anti-citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritis. Arthritis Rheum. 2011;63:3226\u201333.","journal-title":"Arthritis Rheum."},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1136\/ard.2004.031211","volume":"64","author":"MK Koivula","year":"2005","unstructured":"Koivula MK, Aman S, Karjalainen A, Hakala M, Risteli J. Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis? Ann Rheum Dis. 2005;64:1443\u201350.","journal-title":"Ann Rheum Dis."},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580\u20138.","journal-title":"Ann Rheum Dis."},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155\u201363.","journal-title":"Arthritis Rheum."},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1189\/jlb.1204697","volume":"77","author":"SJ Klebanoff","year":"2005","unstructured":"Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol. 2005;77:598\u2013625.","journal-title":"J Leukoc Biol."},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm1637","volume":"13","author":"Z Wang","year":"2007","unstructured":"Wang Z, Nicholls SJ, Rodriguez ER, Kummu O, Horkko S, Barnard J, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007;13:1176\u201384.","journal-title":"Nat Med."},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/annrheumdis-2012-201559","volume":"72","author":"J Shi","year":"2013","unstructured":"Shi J, Willemze A, Janssen GM, van Veelen PA, Drijfhout JW, Cerami A, et al. Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the \u2018AMC-Senshu\u2019 method. Ann Rheum Dis. 2013;72:148\u201350.","journal-title":"Ann Rheum Dis."},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1479-5876-11-224","volume":"11","author":"S Turunen","year":"2013","unstructured":"Turunen S, Koivula MK, Melkko J, Alasaarela E, Lehenkari P, Risteli J. Different amounts of protein-bound citrulline and homocitrulline in foot joint tissues of a patient with anti-citrullinated protein antibody positive erosive rheumatoid arthritis. J Transl Med. 2013;11:224.","journal-title":"J Transl Med."},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1600-0765.2008.01175.x","volume":"44","author":"L Vitkov","year":"2009","unstructured":"Vitkov L, Klappacher M, Hannig M, Krautgartner WD. Extracellular neutrophil traps in periodontitis. J Periodontal Res. 2009;44:664\u201372.","journal-title":"J Periodontal Res."},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1600-051X.2012.01885.x","volume":"39","author":"W Nesse","year":"2012","unstructured":"Nesse W, Westra J, van der Wal JE, Abbas F, Nicholas AP, Vissink A, et al. The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. J Clin Periodontol. 2012;39:599\u2013607.","journal-title":"J Clin Periodontol."},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","volume":"5","author":"R Khandpur","year":"2013","unstructured":"Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med. 2013;5:178ra40.","journal-title":"Sci Transl Med"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1136\/ard.2009.124537","volume":"69","author":"D van der Woude","year":"2010","unstructured":"van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69:1554\u201361.","journal-title":"Ann Rheum Dis."},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/ard.2010.131102","volume":"70","author":"A Ioan-Facsinay","year":"2011","unstructured":"Ioan-Facsinay A, El-Bannoudi H, Scherer HU, van der Woude D, Menard HA, Lora M, et al. Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities. Ann Rheum Dis. 2011;70:188\u201393.","journal-title":"Ann Rheum Dis."},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/ard.2010.135509","volume":"70","author":"P Suwannalai","year":"2011","unstructured":"Suwannalai P, Scherer HU, van der Woude D, Ioan-Facsinay A, der Zijde CM, van Tol MJ, et al. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann Rheum Dis. 2011;70:373\u20139.","journal-title":"Ann Rheum Dis."},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1002\/art.27644","volume":"62","author":"S Turunen","year":"2010","unstructured":"Turunen S, Koivula MK, Risteli L, Risteli J. Anticitrulline antibodies can be caused by homocitrulline-containing proteins in rabbits. Arthritis Rheum. 2010;62:3345\u201352.","journal-title":"Arthritis Rheum."},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3899\/jrheum.130742","volume":"41","author":"M Scinocca","year":"2014","unstructured":"Scinocca M, Bell DA, Racape M, Joseph R, Shaw G, McCormick JK, et al. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins\/peptides. J Rheumatol. 2014;41:270\u20139.","journal-title":"J Rheumatol."},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/art.1780361104","volume":"36","author":"P Hannonen","year":"1993","unstructured":"Hannonen P, Mottonen T, Hakola M, Oka M. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study. Arthritis Rheum. 1993;36:1501\u20139.","journal-title":"Arthritis Rheum"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(89)92442-2","volume":"1","author":"DM van der Heijde","year":"1989","unstructured":"van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989;1:1036\u20138.","journal-title":"Lancet"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1093\/rheumatology\/kel113","volume":"45","author":"MK Koivula","year":"2006","unstructured":"Koivula MK, Aman S, Alasaarela E, Karjalainen A, Hakala M, Risteli J. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45:1364\u20139.","journal-title":"Rheumatology (Oxford)."},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/art.37830","volume":"65","author":"J Shi","year":"2012","unstructured":"Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, et al. Anti carbamylated protein antibodies (anti-CarP) are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2012;65:911\u20135.","journal-title":"Arthritis Rheum."},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1136\/ard.2009.116384","volume":"69","author":"D van der Woude","year":"2010","unstructured":"van der Woude D, Syversen SW, van der Voort EI, Verpoort KN, Goll GL, van der Linden MP, et al. The ACPA isotype profile reflects long-term radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2010;69:1110\u20136.","journal-title":"Ann Rheum Dis."},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, et al. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A. 2011;108:17372\u20137.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","volume":"73","author":"X Jiang","year":"2014","unstructured":"Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Kallberg H, et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis. 2014;73:1761\u20138.","journal-title":"Ann Rheum Dis."},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/art.23188","volume":"58","author":"L Mathsson","year":"2008","unstructured":"Mathsson L, Mullazehi M, Wick MC, Sjoberg O, van Vollenhoven R, Klareskog L, et al. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides. Arthritis Rheum. 2008;58:36\u201345.","journal-title":"Arthritis Rheum."},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"MP van der Linden","year":"2009","unstructured":"van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, et al. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum. 2009;60:2232\u201341.","journal-title":"Arthritis Rheum."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0515-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0515-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0515-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:29:12Z","timestamp":1728923352000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0515-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0515-z","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,9]]},"assertion":[{"value":"13 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"2"}}